Jupiter Neurosciences, Inc. (JUNS) stock
JUNSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.70−0.06 (-3.41%)
Close on Nov 16, 2026Market cap $1.31MP/E –Yield –
Jupiter Neurosciences gross margin
Gross margin is gross profit as a percentage of revenue.
For fiscal 2025 it was 80.6%.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 80.6% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 86.9% | – |
| Q1 FY2026 | Mar 31, 2026 | 76.6% | – |
See a number that looks wrong?